Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Tocris Bioscience™ Tocriscreen™ Kinase Inhibitor Toolbox II

Catalog No. 62251SET
Change view
Click to view available options
Quantity:
80 Kinase Inhibitors
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
62-251-SET 80 Kinase Inhibitors
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
This item is not returnable. View return policy
Catalog No. 62-251-SET Supplier Tocris Bioscience™ Supplier No. 6225/1 SET

Item Discontinued This item has been discontinued by the supplier. Please to view product availability in your area.

This item is not returnable. View return policy

Contains set of kinases for screening.

  • Collection of 80 kinase inhibitors
  • Supplied pre-dissolved in DMSO (250μL 10mM solution)
  • Targets range of 40 different kinases
  • Comprises subset of Tocriscreen Plus (Part. No. 5840) compound library
  • Compounds: LRRK2, PI 3-kinase, mTOR, EGFR, VEGFR
  • Contians novel targets: LIMK, Hapsin, NUAK1 and DYRK
  • Matrix storage tubes with SepraSeal caps

Specifications

Formulation 250μL in 10mM DMSO solutions (pre- dissolved)
Includes Standard kinase inhibitors for targets (LRRK2, PI 3-kinase, mTOR, EGFR, VEGFR), novel targets (LIMK, Hapsin, NUAK1 and DYRK)
Product Type Inhibitor
Content And Storage Store at -20°C
For Use With (Application) Screening for therapeutic classes
Quantity 80 Kinase Inhibitors
Format 96-well

For Laboratory Research Use Only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.